Your browser doesn't support javascript.
loading
Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design.
Friedman, Scott; Sanyal, Arun; Goodman, Zachary; Lefebvre, Eric; Gottwald, Mildred; Fischer, Laurent; Ratziu, Vlad.
Afiliação
  • Friedman S; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, NY, USA. Electronic address: scott.friedman@mssm.edu.
  • Sanyal A; Department of Gastroenterology, Virginia Commonwealth University, Richmond, VA, USA.
  • Goodman Z; Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA, USA.
  • Lefebvre E; Tobira Therapeutics, Inc., South San Francisco, CA, USA.
  • Gottwald M; Tobira Therapeutics, Inc., South San Francisco, CA, USA.
  • Fischer L; Tobira Therapeutics, Inc., South San Francisco, CA, USA.
  • Ratziu V; Institute of Cardiometabolism and Nutrition (ICAN), Hôpital la Pitié Salpêtrière and Université Pierre et Marie Curie, Paris, France.
Contemp Clin Trials ; 47: 356-65, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26944023

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica / Antagonistas dos Receptores CCR5 / Imidazóis / Cirrose Hepática Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica / Antagonistas dos Receptores CCR5 / Imidazóis / Cirrose Hepática Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article